20 March 2020
Health and safety of patients, our employees and their families take the highest priority for NovaMedica. As the COVID-19 situation is developing rapidly, we follow the recommendations of the federal and local authorities to prevent the infection from spreading. On March 19, NovaMedica started operating remotely.
“In addition to the measures taken to protect our employees and prevent the spread of the infection, we are actively working to ensure uninterrupted supplies of our pharmaceutical products to doctors and patients”, says Elena Litvinova, CEO of NovaMedica. “The employees of NovaMedica have all the resources necessary to continue working from home but still as a single united team”.
The company has created a working group to take action to control the virus outbreak. The group led by Deputy CEO Maria Makarova aims to organize efficient operation of the entire team of NovaMedica in the new format and to implement measures to protect the employees.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024